← Eichor
Condition: Multiple System Atrophy Msa Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Multiple System Atrophy Msa

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomograp
EARLY_Phase 1 · 1 location(s) · MODAG GmbH · NCT07617688Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease
NA · 1 location(s) · Ecole Polytechnique Fédérale de Lausanne · NCT06920134MSA-01 in Multiple System Atrophy
Phase 3 · 12 location(s) · Tokyo University · NCT07446894The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy
EARLY_Phase 1 · 1 location(s) · Beijing Tiantan Hospital · NCT06765733A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
Phase 2 · 61 location(s) · Teva Branded Pharmaceutical Products R&D LLC · NCT06568237A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy
Phase 1 · 1 location(s) · iRegene Therapeutics Co., Ltd. · NCT07289477Modifiable Variables in Parkinsonism (MVP)
Phase N/A · 1 location(s) · Bastyr University · NCT02194816Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
NA · 1 location(s) · University Hospital, Bonn · NCT07324330Medical Decision Making in Multiple System Atrophy
NA · 1 location(s) · Medical University Innsbruck · NCT06072105Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypi
Phase N/A · 3 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06846658Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07509125Synaptic Loss in Multiple System Atrophy
Phase N/A · 1 location(s) · University of Exeter · NCT05121012[18F]ACI-15916 PET in α-synucleinopathies
EARLY_Phase 1 · 1 location(s) · AC Immune SA · NCT06891703The CurePSP Genetics Program
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT06647641Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant
NA · 1 location(s) · University of Salerno · NCT06821256Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy
Phase 1/Phase 2 · 2 location(s) · Julien Bally · NCT06831500Multiple System Atrophy Multidisciplinary Clinic
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT03811808Invasive Home Ventilation in Denmark
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT07467187AI-Enhanced Optimization of Acute Levodopa Challenge Test
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT06949865Comprehensive Swallowing Rehabilitation in Patients With MSA
NA · 1 location(s) · Seoul National University Hospital · NCT04782284Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
EARLY_Phase 1 · 1 location(s) · MODAG GmbH · NCT07640555[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD
Phase 2/Phase 3 · 2 location(s) · prof. dr. Koen Van Laere · NCT06120049A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
Phase 2 · 1 location(s) · Tiziana Life Sciences LTD · NCT06868628A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Health
Phase 1 · 2 location(s) · Synusight Biotech (Shanghai) Co., Ltd. · NCT07604116Neurologic Stem Cell Treatment Study
NA · 3 location(s) · MD Stem Cells · NCT02795052
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.